Long-term Cardiac Support with the HeartMate® Vented Electric Left Ventricular Assist System

  • T. J. Myers
  • O. H. Frazier


Over the past 30 years extensive research and development efforts have been aimed at chronic cardiovascular disease, a major health problem in the United States. Although numerous advances have been made in medical and surgical therapy, as well as in preventive medicine, finding a definitive treatment for chronic end-stage heart failure continues to be a great challenge. Current therapies are mostly palliative, and the manifestations of heart failure progress until death. Because a cure for cardiovascular disease is not likely in the near future, the goals of therapy should be to extend life and to improve the quality of life. To achieve these goals the therapy must be reliable, cost-effective, relatively easy to implement and maintain, and able to provide a near physiologic level of support.


Pulmonary Capillary Wedge Pressure Chronic Heart Failure Patient Circulatory Support Blood Pump Mechanical Circulatory Support 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Furnary AP, Magovern JA. Chrislieb IY. Orie JE, Simpson KA, Magovern GJ. Clinical cardiomyoplasty: preoperalive factors associated with outcome. Ann Thorac Surg. 1992;54:1139–43.PubMedGoogle Scholar
  2. 2.
    Lu CY, Khair-el-Din TA, Davidson IA et al. Xenotransplantation. FASEB J. 1994;8:1122–30.PubMedGoogle Scholar
  3. 3.
    Funk D. Epidemiology of end-stage heart disease. In: The artificial heart: prototypes, policies, and patients. Committee to Evaluate the Artificial Heart Program of the National Heart, Lung, and Blood Institute. Washington, DC: National Academy Press; 1991:251.Google Scholar
  4. 4.
    Cooley DA, Liotta D, Mailman UL, Bloodwell RD, Leachman RD, Milam JD. Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am J Cardiol. 1969;24:723–30.PubMedCrossRefGoogle Scholar
  5. 5.
    Joyce LD, Johnson KH, Cabrol C el al. Nine years experience with the clinical use of total artificial hearts as cardiac support devices. Trans Am Soc Artif Intern Organs. 1988;24:703–7.Google Scholar
  6. 6.
    Frazier OH, Rose E, McManus Qet al. Multicenter evaluation of the HeartMate 1000 IP left ventricular assist device. Ann Thorac Surg. 1992;53:1080–90.PubMedGoogle Scholar
  7. 7.
    Frazier OH, Maeris MP, Myers TJ et al. Improved survival after extended bridge to cardiac transplantation. Ann Thorac Surg. 1994;57:1416–22.PubMedGoogle Scholar
  8. 8.
    Dasse KA, Frazier OH, Lesniak JM, Myers TJ, Burnett CL, Poirier VL. Clinical responses to ventricular assistance versus transplantation in a series of bridge to transplant patients. ASAIO J. 1992;38:M622–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Frazier OH. Ventricular assistance: a perspective on the future. Heart Failure. 1995;10:259–64.Google Scholar
  10. 10.
    Szycher M, Clay W, Genies, D, Sherman C. Thermedics’ approach to ventricular support systems. J Biomaler Appl. 1986;1:39–105.Google Scholar
  11. 11.
    Rose EA, Levin HR, Oz MC et al. Artificial circulatory support with textured interior surfaces. A counterintuitive approach to minimizing thromboembolism. Circulation. 1994;90:1187–91.Google Scholar
  12. 12.
    Dasse KA, Chipman SD, Sherman CN, Levine AH, Frazier OH. Clinical experience with textured blood contacling surfaces in ventricular assist devices. Trans Am Soc Artif Intern Organs. 1987;23:418–25.Google Scholar
  13. 13.
    Graham TR, Dasse KA, Coumbe A et al. Neo-intimal development on textured biomaterial surfaces during clinical use of an implantable left ventricular assist device. Eur J Cardiothorac Surg. 1990;4:182–90.PubMedCrossRefGoogle Scholar
  14. 14.
    De Vries WC. The permanent artificial heart: four case reports. J Am Med Assoc. 1988;259:849–59.CrossRefGoogle Scholar
  15. 15.
    McCarthy PM, Wang N, Vargo R. Preperitoneal insertion of the HeartMate 1000 IP implantable left ventricular assist device. Ann Thorac Surg. 1994;57:634–8.PubMedGoogle Scholar
  16. 16.
    Radovancevic B, Frazier OH, Duncan JM. Implantation technique for the HeartMate left ventricular assist device. J Card Surg. 1992;7:203–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Parnis SM, McGee MG, Igo SR, Dasse K, Frazier OH. Anatomic considerations for abdominally placed permanent left ventricular assist devices. ASAIO Trans. 1988;35:728–30.CrossRefGoogle Scholar
  18. 18.
    Capek P, Kadipasaoglu KA, Radovancevic Bet a. Human intraperitoncal response to a left ventricular assist device with a Ti-6A1-4V alloy surface. ASAIO J. 1992;38:M543–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Poirier VL, Frazier OH. Portable electric systems for long term use. In: Akutsu T, Koyanagi H, editors. Heart replacement: artificial heart 4. The 4th International Symposium on Artificial Heart and Assist Devices. Berlin: Springer-Verlag; 1993:103–14.Google Scholar
  20. 20.
    Frazier OH, Rose EA, McCarthy Pet al. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg. 1995;222:327–38.PubMedCrossRefGoogle Scholar
  21. 21.
    Goldsmith MF. First implant of portable heart-assist device. J Am Med Assoc. 1991;265:2930–1.CrossRefGoogle Scholar
  22. 22.
    Myers TJ, Dasse KA, Maeris MP, Poirier VL, Cloy MJ, Frazier OH. Use of a left ventricular assist device in an outpatient setting. ASAIO J. 1994;40:M471–5.PubMedCrossRefGoogle Scholar
  23. 23.
    Levin HR, Chen JM, Oz MC, et al. Potential of left ventricular assist devices as out-patient therapy while awaiting transplantation. Ann Thorac Surg. 1994;58:1515–20.PubMedGoogle Scholar
  24. 24.
    Burnett CM, Duncan JM, Frazier OH, Sweeney MS, Vega JD. Radovancevic B. Improved multiorgan function after prolonged univentricular support. Ann Thorac Surg. 1993;55:65–71.PubMedGoogle Scholar
  25. 25.
    McCarthy PM, Savage RM, Fraser CD et a. Hcmodynamic and physiologic changes during support with an implantable left ventricular assist device. J Thorac Cardiovasc Surg. 1995;109:409–17.PubMedCrossRefGoogle Scholar
  26. 26.
    Kormos RL, Murali S, Dew MAet al. Chronic mechanical circulatory support: reha-bilitation, low morbidity, and superior survival. Ann Thorac Surg. 1994;57:51–8.PubMedGoogle Scholar
  27. 27.
    Granfeldt H, Solem JO, Lonn U et al. The Linkoping-Lund surgical experience with the HeartMate left ventricular assist system. Ann Thorac Surg. 1995:59(Suppl. 2):S52–5.PubMedCrossRefGoogle Scholar
  28. 28.
    Frazier OH. First use of an untethered, vented electric left ventricular assist device for long-term support. Circulation. 1994;89:2908–14.PubMedGoogle Scholar
  29. 29.
    Scheinin SA, Capek P, Radovancevic B, Duncan JM, McAllister HA, Frazier OH. The effect of prolonged left ventricular support on myocardial histopathology in patients with end-stage cardiomyopathy. ASAIO J. 1992;38:M271–4.PubMedCrossRefGoogle Scholar
  30. 30.
    McCarthy PM, James KB, Savage RMet al. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD study group. Circulation. 1994;90(5):II83–6.PubMedGoogle Scholar
  31. 31.
    Levin HR, Chen JM, Oz MCet al. Potential of left ventricular assist devices as outpatient therapy while awaiting transplantation. Ann Thorac Surg. 1994;58:1515–20.PubMedGoogle Scholar
  32. 32.
    Cloy MJ, Myers TJ, Stutts LA, Maerisv MP, Frazier OH. Hospital charges for conventional therapy versus left ventricular assist system therapy in heart transplant patients. ASAIO J 1995;41:M535–9.PubMedGoogle Scholar
  33. 33.
    Poirier VL. Can our society afford mechanical hearts? ASAIO Trans. 1991;37:540–4.PubMedGoogle Scholar
  34. 34.
    Ho KKL, Anderson KM, Kannel WB et al. Survival after onset of congestive heart failure in Framingham Heart Study patients. Circulation. 1993;88:107–15.PubMedGoogle Scholar
  35. 35.
    Poirier VL.The quest for a solution. We must continue. We must push forward. 16th Hastings Lecture. ASAIO J. 1993;39:856–63.Google Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • T. J. Myers
  • O. H. Frazier

There are no affiliations available

Personalised recommendations